Association of Quantitative and Functional Imaging With Clinical Outcome After Spinal Cord Injury
NCT ID: NCT03886610
Last Updated: 2023-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
57 participants
OBSERVATIONAL
2019-03-27
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Imaging of Cognitive Deficits in the Brain of Individuals With Spinal Cord Injury
NCT06309888
Using Muscle Functional MRI to Study Spatial Muscle Activation Patterns in People With SCI
NCT07073313
CNS Changes Following SCI
NCT03772548
A Comprehensive Assessment of Altered Embodiment in Individuals With Spinal Cord Injury
NCT06688916
Spinal Cord Injury: Impact on Sensory, Motor, Behavioral and Cognitive Functions
NCT06887309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conventional magnetic resonance imaging (MRI) is the current standard to assess morphologic changes of the spinal cord after injury. However, conventional MRI provides little information regarding the health and integrity of the brain and spinal cord tissue itself, due to the fact that signal intensity changes are non-specific and do not correspond directly with physiological processes. This is reflected in the poor correlation of conventional MRI data with neurological and functional impairment in various spinal cord pathologies (such as multiple sclerosis compression myelopathy) and failure to provide reliable prognostic information.
By applying a combination of diffusion weighted imaging, functional MRI and magnetic resonance spectroscopy will give us a better understanding of the changes after injury of the cervical spinal cord, brainstem and brain. Correlating the imaging data with the neurological and clinical status of patients could improve the patient status prediction and therapy planning.
This study is divided into three sub-projects:
i) Reproducibility study of the MR measurements in healthy controls ii) Progression of MR biomarkers in subacute patients with SCI and comparison to chronic patients with SCI iii) Prediction of clinical outcome based on MR biomarkers
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy controls
Individuals without spinal cord injury
Healthy controls
individuals without spinal cord injury
Subacute SCI patients
Subacute patients with spinal cord injury (duration \>2 weeks)
Subacute SCI patients
individuals with spinal cord injury ≥ 2 weeks
Chronic SCI patients
Patients with chronic spinal cord injury (duration ≥24 months)
Chronic SCI patients
individuals with spinal cord injury ≥ 24 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Healthy controls
individuals without spinal cord injury
Subacute SCI patients
individuals with spinal cord injury ≥ 2 weeks
Chronic SCI patients
individuals with spinal cord injury ≥ 24 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no previous history of severe cervical trauma, traumatic brain injury, cervical surgery or signs of neurological impairment and no known neurological disease.
Subacute and chronic patients with spinal cord injury:
* lesion level at or below C3
* etiology of the spinal cord injury is traumatic or non-traumatic
* age between 18 and 80 years
* time of trauma or onset of symptoms for subacute SCI patients is more than 3 weeks and for the chronic SCI patients more than 2 years
Exclusion Criteria
* unable to give consent
* lesion level below L2
* other known pathology of the spinal cord/brain (e.g. MS) or progressive neurological disorders
* inability to meet the MRI screening requirements (e.g. pacemaker or other electronic devices),
* severe head trauma as defined by a Glasgow Coma Scale (GCS) of \< 14
* patients who are ventilator dependant
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UMC Utrecht
OTHER
Swiss Paraplegic Research, Nottwil
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christiaanse Ernst
Radiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ernst Christiaanse, MD
Role: PRINCIPAL_INVESTIGATOR
Swiss Paraplegic Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Swiss Paraplegic Centre
Nottwil, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-37
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.